Announcement

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Certara integrates D360 with Secondary Intelligence to help drug researchers identify off-target safety risks earlier…

CertaraJune 12, 2026

Announcement

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

Certara was reappointed to a 4 year EMA and ECDC framework contract to generate real-world…

CertaraJune 11, 2026

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

CertaraJune 11, 2026

Blog

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…

CertaraJune 11, 2026

Live Events

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

June 30, 2026 - 12:00 PM – 2:00 PM

CertaraJune 10, 2026

Webinar

Model Smarter, Not Harder: Introducing Model Designer

June 30, 2026, 10:00 – 11:00 AM ET | July 2, 2026, 10:00 – 11:00…

Danielle PillsburyJune 10, 2026

Poster

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…

CertaraJune 9, 2026

Poster

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.

CertaraJune 9, 2026

Blog

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…

CertaraJune 9, 2026

Blog

How interactive value communication tools strengthen the value proposition in healthcare

Learn how interactive value communication tools help demonstrate healthcare value, support payer discussions, and strengthen…

CertaraJune 9, 2026

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

2026 Simcyp Workshops

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

Model Smarter, Not Harder: Introducing Model Designer

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

How interactive value communication tools strengthen the value proposition in healthcare

Newsletter sign up

Quick links

Solutions

Contact